Cassie Jung Aquestive Therapeutics, Inc. (AQST) insider trading activity

AQST Quotes by TradingView

Cassie Jung is Chief Operating Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 237,754 shares of AQST, which is worth approximately $855,914. The most recent transaction as insider was on Mar 10, 2024, when has been sold 1,132 shares (Common Stock) at a price of $4.88 per share, resulting in proceeds of $5,524. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 238K
0% 3M change
62.92% 12M change
Total Value Held $855,914

Cassie Jung Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2024
SELL
Payment of exercise price or tax liability
$5,524 $4.88 p/Share
1,132 Reduced 0.47%
237,754 Common Stock
Mar 09 2024
SELL
Payment of exercise price or tax liability
$40,504 $4.88 p/Share
8,300 Reduced 3.36%
238,886 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
101,250 Added 29.06%
247,186 Common Stock
Mar 10 2023
SELL
Payment of exercise price or tax liability
-
1,365 Reduced 0.93%
145,936 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
110,000 Added 42.84%
146,747 Common Stock
CJ

Cassie Jung

Chief Operating Officer
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AQST